Cargando…

Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance

As a cancer stem cell marker, CD44 variant 6 (CD44v6) has been implicated in carcinogenesis, tumor progression, and metastasis in a variety of human carcinomas. However, little is known about the expression of CD44v6 in Gastric Carcinoma (GC). Therefore we investigated CD44v6 expression in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yuan-Yuan, Guo, Ming, Yang, Liu-Qing, Zhou, Fan, Yu, Cao, Wang, Aixiu, Pang, Tao-Hong, Wu, Hong-Yan, Zou, Xiao-Ping, Zhang, Wei-Jie, Wang, Lei, Xu, Gui-Fang, Huang, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542232/ https://www.ncbi.nlm.nih.gov/pubmed/28507278 http://dx.doi.org/10.18632/oncotarget.17435

Ejemplares similares

Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis
por: Zhang, Yunyuan, et al.
Publicado: (2015)

Expression of CD44v6 and lymphatic vessel density in early gastric cancer tissues and their clinical significance
por: Sun, Yuting, et al.
Publicado: (2019)

Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer
por: Hu, Bangli, et al.
Publicado: (2015)

Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma
por: Gun, Banu Dogan, et al.
Publicado: (2012)

Acetylation and activation of STAT3 mediated by nuclear translocation of CD44
por: Lee, Jia-Lin, et al.
Publicado: (2009)

Associations of potentially functional variants in IL-6, JAKs and STAT3 with gastric cancer risk in an eastern Chinese population
por: Zhou, Fei, et al.
Publicado: (2016)

Different Associations of CD45 Isoforms with STAT3, PKC and ERK Regulate IL-6-Induced Proliferation in Myeloma
por: Zheng, Xu, et al.
Publicado: (2015)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Role of IL-6/STAT3 Axis in Resistance to Cisplatin in Gastric Cancers
por: Laurino, Simona, et al.
Publicado: (2023)

The clinical significance of CD44v6 in malignant and benign primary bone tumors
por: Hosseini, Ameinh, et al.
Publicado: (2023)

Expression of Bmi-1, P16, and CD44v6 in Uterine Cervical Carcinoma and Its Clinical Significance
por: Weng, Mei-ying, et al.
Publicado: (2012)

Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands
por: Laohavisudhi, Fonthip, et al.
Publicado: (2022)

Clinical and Prognostic Significance of HIF-1α, PTEN, CD44v6, and Survivin for Gastric Cancer: A Meta-Analysis
por: Chen, Jing, et al.
Publicado: (2014)

HBV replication is significantly reduced by IL-6
por: Kuo, Tzer-Min, et al.
Publicado: (2009)

Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses
por: Xia, Pu, et al.
Publicado: (2016)

Knockdown of RNF6 inhibits gastric cancer cell growth by suppressing STAT3 signaling
por: Huang, Ziming, et al.
Publicado: (2018)

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
por: Wang, Zhe, et al.
Publicado: (2018)

RHOJ Induces Epithelial-to-Mesenchymal Transition by IL-6/STAT3 to Promote Invasion and Metastasis in Gastric Cancer
por: Ma, Zhijie, et al.
Publicado: (2023)

Modulation of CD44 Activity by A6-Peptide
por: Finlayson, Malcolm
Publicado: (2015)

The Prognostic Significance of CD44V6, CDH11, and β-Catenin Expression in Patients with Osteosarcoma
por: Deng, Zhouming, et al.
Publicado: (2013)

Diagnostic accuracy of CD44V6 for osteosarcoma: a meta-analysis
por: Zhang, Yunyuan, et al.
Publicado: (2016)

IL-6 Inhibition Reduces STAT3 Activation and Enhances the Antitumor Effect of Carboplatin
por: Wang, Zhi-Yong, et al.
Publicado: (2016)

IL-4 and IL-13 Promote Proliferation of Mammary Epithelial Cells through STAT6 and IRS-1
por: Wu, Wan-Ju, et al.
Publicado: (2021)

CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis
por: Wang, Ji-Lin, et al.
Publicado: (2016)

IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK/STAT6 activation
por: Chao, Hua, et al.
Publicado: (2023)

IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells
por: Cao, Hui, et al.
Publicado: (2016)

Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells
por: Pereira, Carla, et al.
Publicado: (2020)

AB109. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival
por: Qin, Jun, et al.
Publicado: (2014)

Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas
por: Zhou, Dang-xia, et al.
Publicado: (2012)

IL-6-STAT3 signaling and premature senescence
por: Kojima, Hirotada, et al.
Publicado: (2013)

The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer
por: Jang, Byung Ik, et al.
Publicado: (2011)

RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling
por: Liu, Mengyuan, et al.
Publicado: (2022)

Reciprocal regulation of miR‐206 and IL‐6/STAT3 pathway mediates IL6‐induced gefitinib resistance in EGFR‐mutant lung cancer cells
por: Yang, Yanhua, et al.
Publicado: (2019)

Mecp2 protects kidney from ischemia-reperfusion injury through transcriptional repressing IL-6/STAT3 signaling
por: Wang, Jiao, et al.
Publicado: (2022)

The IL-6–STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression
por: Zhu, Q, et al.
Publicado: (2014)

Activation of STAT3 in Human Gastric Cancer Cells via Interleukin (IL)-6-Type Cytokine Signaling Correlates with Clinical Implications
por: Wang, Zhengguang, et al.
Publicado: (2013)

Dual STAT-3 and IL-6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL-6/IL-6R/STAT-3 axis
por: Méndez-Clemente, Anibal, et al.
Publicado: (2022)

IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Junnv, et al.
Publicado: (2021)

CD44v6 engages in colorectal cancer progression
por: Ma, Lixin, et al.
Publicado: (2019)

Understanding the role of CD44V6 in ovarian cancer
por: Zhang, Hui-Feng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_di16lfrucd3kcfns8o2e498qa1